Australasian recurrent pregnancy loss clinical management guideline 2024, part II

Adriana Suker, L. I. Ying, Danielle Robson, Anthony Marren, the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial Evidence (ACCEPT) group, Neil Johnson, Neerja Kamal, Sarah Hunter

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
31 Downloads (Pure)

Abstract

Part II of the Australasian guideline for the investigation and management of recurrent pregnancy loss (RPL) provides evidence-based guidance on the management of RPL provided. The implications of inherited and acquired thrombophilia with respect to RPL and suggestions for clinical management are provided. Autoimmune factors, including human leukocyte antigen, cytokines, antinuclear antibodies and coeliac antibodies, and guidance for management are discussed. Infective, inflammatory and endometrial causes of RPL are discussed in detail. Environmental and lifestyle factors, male factor and unexplained causes are outlined. Levels of evidence and grades of consensus are provided for all evidence-based statements.

Original languageEnglish
Pages (from-to)445-458
Number of pages14
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume64
Issue number5
DOIs
Publication statusPublished - Oct 2024

Keywords

  • guideline
  • recurrent miscarriage
  • recurrent pregnancy loss
  • RPL

Fingerprint

Dive into the research topics of 'Australasian recurrent pregnancy loss clinical management guideline 2024, part II'. Together they form a unique fingerprint.

Cite this